Targeting Tumor Acidity Pathway Shows Promise in Ovarian Cancer
July 31, 2026 | by Aaditya Raj

Researchers at UT MD Anderson found that targeting tumor acidity pathway in ovarian cancer cells can help overcome PARP inhibitor resistance by restoring treatment response.
Curated in the public interest from original reporting.
Read full story at Medical Xpress →
RELATED POSTS
View all
